🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to evaluate the immunogenicity, the safety and...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-06-05
Trial ID
NCT02106390
Treatments Being Tested
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923
The primary objective of this study is to demonstrate the equivalence of rM...
Status
Completed
Location
Royal Children's Hospital
Start Date
2011-08
Trial ID
NCT01423084
Treatments Being Tested
The proposed study is aimed to assess the antibody response and short-term ...
Status
Completed
Location
Site 13: Liceo Diego Aracena de Lo Barnechea
Start Date
2008-06
Trial ID
NCT00661713
Treatments Being Tested
One year antibody persistence after the fourth dose boost or two catch-up d...
Status
Completed
Location
amostatná ordinace praktického lékaře pro děti a dorost Jindřichův Hradec
Start Date
2010-06
Trial ID
NCT01139021
Treatments Being Tested
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
The purpose of this study is to assess the safety and immune responses of r...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2023-11-10
Trial ID
NCT06113198
Treatments Being Tested
The purpose of this trial is to assess the safety of a Meningococcal Group ...
Status
Completed
Location
01, Novartis Investigational Site
Start Date
2014-12
Trial ID
NCT02305446
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of B...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-27
Trial ID
NCT03621670
The purpose of the current study is to evaluate whether there is immune int...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-09
Trial ID
NCT03587207
Treatments Being Tested